Form 13-F position report

INSMED INC

Reported by THE BANK OF NEW YORK MELLON CORPORATION

INSM 0.75 06/01/28 CUSIP 457669AB5 Manager CIK 0001390777

Reported 500,000 shares, unchanged from the prior quarter.

Reported value -10.3%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q1 2022
Shares 500,000 Quarter-end amount reported
Reported value $486,000 Fair value at quarter end
Consecutive quarters held 3 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 550000
2021-12-31 542000
2022-03-31 486000
2022-06-30 405000
2022-09-30 362000
2022-12-31 330461
2023-03-31 311448
2023-06-30 339132
2023-09-30 397244
2023-12-31 458996
2024-03-31 430120
2024-06-30 423566
2024-09-30 459950
2024-12-31 217334
2025-03-31 237335
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for INSMED INC held by THE BANK OF NEW YORK MELLON CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -100,000 (-100.0%) 0 $0 2025-08-05
Q1 2025 Unchanged 100,000 0 (0.0%) < 0.01% $237,335 2025-04-29
Q4 2024 Reduced 100,000 -100,000 (-50.0%) < 0.01% $217,334 2025-02-04
Q3 2024 Unchanged 200,000 0 (0.0%) < 0.01% $459,950 2024-11-12
Q2 2024 Reduced 200,000 -200,000 (-50.0%) < 0.01% $423,566 2024-07-25
Q1 2024 Unchanged 400,000 0 (0.0%) < 0.01% $430,120 2024-04-25
Q4 2023 Unchanged 400,000 0 (0.0%) < 0.01% $458,996 2024-01-29
Q3 2023 Unchanged 400,000 0 (0.0%) < 0.01% $397,244 2023-10-24
Q2 2023 Unchanged 400,000 0 (0.0%) < 0.01% $339,132 2023-08-03
Q1 2023 Unchanged 400,000 0 (0.0%) < 0.01% $311,448 2023-05-09
Q4 2022 Unchanged 400,000 0 (0.0%) < 0.01% $330,461 2023-02-14
Q3 2022 Reduced 400,000 -100,000 (-20.0%) < 0.01% $362,000 2022-11-14
Q2 2022 Unchanged 500,000 0 (0.0%) < 0.01% $405,000 2022-08-15
Q1 2022 Unchanged 500,000 0 (0.0%) < 0.01% $486,000 2022-05-11
Q4 2021 Unchanged 500,000 0 (0.0%) < 0.01% $542,000 2022-02-11
Q3 2021 New 500,000 +500,000 (0.0%) < 0.01% $550,000 2021-11-12

Who else reported the position

54 managers reported INSMED INC for Q1 2022.

Managers reporting INSMED INC in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CITADEL ADVISORS LLC Added 120,537,000 +2,883,000 0.02% $117,236,000 4 qtrs
FRANKLIN RESOURCES INC Unchanged 60,000,000 0 0.02% $58,140,000 4 qtrs
LAZARD ASSET MANAGEMENT LLC Added 41,196,000 +1,689,000 0.05% $39,918,000 4 qtrs
Allianz Asset Management GmbH Unchanged 40,990,000 0 0.03% $39,833,000 3 qtrs
BAKER BROS ADVISORS LP Unchanged 40,000,000 0 0.22% $38,614,000 4 qtrs
LORD ABBETT & CO LLC Reduced 34,402,000 -190,000 0.09% $33,335,000 4 qtrs
CAPSTONE INVESTMENT ADVISORS LLC Added 33,877,000 +4,000,000 0.09% $32,827,000 4 qtrs
Linden Advisors LP Unchanged 26,416,000 0 0.16% $25,689,000 4 qtrs
AVIVA PLC Unchanged 25,000,000 0 0.12% $24,295,000 4 qtrs
AMERIPRISE FINANCIAL INC Reduced 23,300,000 -2,000,000 < 0.01% $22,462,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 11, 2022
Filing type
13F-HR
Position type
NOTE

Voting authority reported

Sole
500,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.